Saturday, December 9, 2017

Capital Square 1031 Acquires Newly Constructed Medical Office Building Near Bakersfield, CA.

Louis Rogers
BAKERSFIELD, CA – Capital Square 1031, a leading real estate investment and management firm specializing in Delaware statutory trust investments, has acquired a newly-constructed medical office building providing specialty dialysis services near Bakersfield, California.

Located at 711 Valley Blvd. in Tehachapi, California, the property is 100 percent leased on a long-term, absolute net basis with yearly rent escalations to Sanderling Renal Services, a healthcare firm specializing in dialysis and nephrology services. The building is conveniently located near the recently completed Adventist Health Tehachapi Valley hospital.

“Acquisition of the Tehachapi property marks Capital Square’s 20th medical office building under management and aligns well with our investment strategy of acquiring stable, high quality real estate assets,” says Louis Rogers, founder and chief executive officer of Capital Square 1031. 

“The building is poised for long-term stability due to the lack of competition, coupled with the growing demand for healthcare services in the area.”

The property was acquired on an all cash, no debt basis, as part of a Delaware statutory trust offering primarily for investors structuring Section 1031 tax-deferred exchanges. A growing number of high net worth investors are seeking quality Section 1031 replacement property on an all cash basis. This is Capital Square’s 40th DST offering and 60th property acquisition to-date.

Sanderling Renal Services is focused on providing convenient access to high quality dialysis and nephrology services in rural areas. With more than 25 years of combined experience, the executives at Sanderling are focused on providing products and services for people with end stage renal disease while establishing a trusted relationship with local hospitals ensuring the continuity of care for patients.

For more information on this transaction, please contact:

Julie Leber     
Spotlight Marketing Communications 
949.427.5172, ext. 703 

No comments: